52-Week Performance Chart

Powered by FactSet Research Systems Inc

No DR Special Notices are available.

No DR Events are available.

Data provided by Thomson Reuters

Institutional Ownership

TOP INSTITUTIONAL HOLDERS POSITION
TOP MUTUAL FUND HOLDERS POSITION

Data provided by FactSet Research Systems Inc.

DR Details

DR Symbol ORXOY
CUSIP 68616W102
DR Venue OTCQX
DR ISIN US68616W1027
Ratio DR:ORD 1:1
Underlying ISIN SE0000736415
Country Sweden
Effective Date Sep 09, 2013
Depositary CIT (Sponsored)
Industry Pharma. & Biotech.
Orexo is an integrated pharma company with commercial operations in the U.S. and research and development in Sweden. The Company's focus is primarily on opioid dependence and pain. The Company's product portfolio includes Zubsolv®, a product for the treatment of opioid dependence; Abstral®, a sublingual tablet for the treatment of breakthrough cancer pain in patients; and Edluar®, for the treatment of short-term insomnia. The Company's development projects include OX124 and OX125, both for treatment of opiod overdose; OX338 to treat moderate to moderately severe pain; and OX-MPI, to treat microvascular disease.

Data provided by Mergent, Inc.

Fee Type in US Dollar per ADS Deposit Agreement
Cable Fee per Cancellation $17.5000

Monthly Trading Summary

More
Month Month End DR Close Price DR Trading Volume Avg Day DR Trading Volume
Jun.25 -1.00 n/a n/a
May.25 -1.00 n/a n/a
Apr.25 -1.00 n/a n/a

Powered by FactSet Research Systems Inc.

This information and data is provided for general informational purposes only.  Certain displayed prices may not reflect direct quotes from any market or exchange, but may instead reflect an approximation of price based on a methodology that includes a calculation that includes the price of underlying securities and foreign exchange rate selected for such purpose. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to Terms of Use

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE